Please Wait.....
Report
Radiomics Market - Global Industry Size, Share, Trends, Competition, Opportunity and Forecast, 2018-2028 Segmented By Modality (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron-Emission-Tomography (PET), Others), By Image Type (2D v/s 3D), By Technology (Engineered Features v/s Deep Learning), By Application (Nuclear Medicine, Medical Imaging, Precision Medicine, Oncology, Others), By Region and Competition
Market Report I 2023-03-01 I 118 Pages I TechSci Research
Global Radiomics Market is projected to grow at a formidable rate in the forecast period, 2018-2028. This can be attributed to the growing prevalence of various chronic diseases such as cancer which require accurate diagnosis and treatment. According to the global cancer observatory, the total number of new cancer cases reported in 2020 was around 19,292,789. Out of this, 10,065,305 new cancer cases were reported in males, and in females were around 9,227,484 in 2020. The rising need of improving disease diagnosis, prognosis, and clinical decision support is expected to create new prospects for the growth of global radiomics market.
Radiomics is a quantitative method of approaching medical imaging that seeks to improve the data already available to doctors through sophisticated mathematical analysis. Using analysis techniques from the field of artificial intelligence, radiomics evaluate textural information by mathematically extracting the spatial patterns of signal intensities and pixel interconnections. The potential of radiomics to improve clinical decision-making has been highlighted by numerous research from various imaging domains that have been published so far. The numerous technical parameters impacting the retrieved radiomic properties are the primary cause of the numerous significant hurdles the area is currently facing.
Increased Digitization and Use of Artificial Intelligence in the Healthcare Industry
The digitization of information, produced during normal clinical procedures has increased steadily in medicine over the past few decades, much like it has in many other spheres of human endeavor. As more medical records were made available in digital form, ever-evolving, and more complex software was created to analyze them. At the same time, research on artificial intelligence (AI) has long advanced to the point where its techniques and software tools are sophisticated enough to leave computer science departments and find use in an expanding number of fields. As a result, the medical industry has seen a significant rise in the use of AI applications in recent years. These apps are intended to help clinical decision-making and simplify the repetitive tasks that physicians must perform daily.
Radiomics enhances the available data to physicians with the help of modern mathematical analysis. The concept of radiomics has been most widely implied in the field of oncology basically on the assumption of the presence of certain disease-specific information not perceptible by the human eye in biomedical images.
Different modalities can aid in radiomics analysis on medical images, employing the potential additive value of imaging information retrieved from positron-emission-tomography (PET), computed tomography (CT), and magnetic resonance imaging (MRI), rather than assessing each modality on its own, thus permitting an integrated cross-modality approach. Therefore, the integration of AI into the healthcare industry will fuel the global radiomics market in the future.
Increased Dependency on Radiology for Medical Diagnosis
Medical Imaging procedures facilitate diagnosis and pave an approach for the treatment of adults as well as children and lately, there has been a remarkable rise in the use of these techniques.
Between October 2018 and September 2019, about 45.2 million imaging tests were carried out in England, according to a report by the National Health Service (NHS). Out of these, 3.58 million imaging tests were just conducted in September 2019.
This escalation can be attributed to increased demand by physicians and patients, technological improvements, and better financial conditions for people. Computed Tomography or CT scans have seen a rise of about 8% in the past ten years. It has been revealed by a survey that the rate of CT scans being conducted for respiratory diseases in the emergency department has increased by four folds between 2001 and 2010.
Technological advancements have led to more physicians calling for CT scans and MRIs even for conditions that could be investigated with simpler imaging techniques. An improved view of pathologies can be obtained from a CT scan than a plain radiograph. For example, the best imaging technique suitable for identification and follow-up on pulmonary embolism is CT pulmonary angiography. The chief reason for this is its fast speed and high resolution. CT scan has greater sensitivity and specificity along with enhanced visualization due to which it has the potential to identify small opacities that might have been skipped during chest X-rays. Also, it can offer improved views of some regions such as lung lingula and lung bases. This increased dependency on radiology for medical diagnosis is offering lucrative growth opportunities for the global radiomics market.
Growing Geriatric Population and Associated Diseases
With advancing age, the risk of contracting a disease also increases. Nearly 80% of elderly people in the United States have at least one chronic disease, according to the Centers for Disease Control and Prevention (CDC). Furthermore, it has been estimated by the American Medical Association (AMA) that about 60% of individuals with an age of 65 or above will be living with more than one chronic condition by the year 2030. Therefore, the rise in the geriatric population in the world will fuel the necessity for better healthcare facilities and modern treatment options as well as medications.
The increased incidences of chronic diseases worldwide will drive the demand for modern diagnostic and treatment options. Radiology techniques or medical imaging procedures such as Magnetic Resonance Imaging (MRI), Computed Tomography (CT) scans, ultrasound, and angiography are principally deployed for clinical procedures carried out for several cancers. Also, with a rise in unhealthy lifestyle habits and a rising elderly population, the incidence of cancer is on a surge across several countries, thereby raising the acceptance of novel technologies like radiomics. Hence, the growing geriatric population along with rising cancer cases will propel the global radiomics market.
Market Segmentation
Global radiomics market can be segmented based on modality, image type, technology, application, region, and company. Based on modality, the market is segmented into magnetic resonance imaging (MRI), computed tomography (CT), positron-emission tomography (PET), and others. Based on image type, the market is split into 2D and 3D. Based on technology, the market is divided into engineered features and deep learning. Based on application, the market is fragmented into nuclear medicine, medical imaging, precision medicine, oncology, and others.
Company Profiles
Some of the leading players operating in the global radiomics market are Radiomics.io (Computational Imaging & Bioinformatics Lab), Radiomics Bio (Belgium), Health Innovation Ventures (HIV), Sophia Genetics SA, HealthMyne Inc, Oncoradiomics, and ptTheragnostic BV, among others.
Report Scope:
In this report, global radiomics market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
- Radiomics Market, By Modality:
o Magnetic Resonance Imaging (MRI)
o Computed Tomography (CT)
o Positron-Emission-Tomography (PET)
o Others
- Radiomics Market, By Image Type:
o 2D
o 3D
- Radiomics Market, By Technology:
o Engineered Features
o Deep Learning
- Radiomics Market, By Application:
o Nuclear Medicine
o Medical Imaging
o Precision Medicine
o Oncology
o Others
- Radiomics Market, By Region:
o North America
- United States
- Mexico
- Canada
o Europe
- France
- Germany
- United Kingdom
- Italy
- Spain
o Asia-Pacific
- China
- India
- Japan
- South Korea
- Australia
o South America
- Brazil
- Argentina
- Colombia
o Middle East & Africa
- South Africa
- Saudi Arabia
- UAE
- Kuwait
Competitive Landscape
Company Profiles: Detailed analysis of the major companies present in the global radiomics market.
Available Customizations:
With the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:
Company Information
- Detailed analysis and profiling of additional market players (up to five).
1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Voice of Customer
4.1. Brand Awareness
4.2. Impact of Radiomics on Different Therapeutic Areas
4.3. Barriers to Adoption of Radiomics
5. Clinical Trial Analysis
5.1. Ongoing Clinical Trials
5.2. Completed Clinical Trials
5.3. Terminated Clinical Trials
5.4. Breakdown of Pipeline, By Development Phase
5.5. Breakdown of Pipeline, By Status
5.6. Breakdown of Pipeline, By Study Application
5.7. Breakdown of Pipeline, By Region
5.8. Clinical Trials Heat Map
6. Patents Analysis
7. Global Radiomics Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1. By Modality (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron-Emission-Tomography (PET), Others)
7.2.2. By Image Type (2D v/s 3D)
7.2.3. By Technology (Engineered Features v/s Deep Learning)
7.2.4. By Application (Nuclear Medicine, Medical Imaging, Precision Medicine, Oncology, Others)
7.2.5. By Region
7.2.6. By Company (2022)
7.3. Product Market Map
7.3.1. By Modality
7.3.2. By Image Type
7.3.3. By Technology
7.3.4. By Application
7.3.5. By Region
8. North America Radiomics Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1. By Modality (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron-Emission-Tomography (PET), Others)
8.2.2. By Image Type (2D v/s 3D)
8.2.3. By Technology (Engineered Features v/s Deep Learning)
8.2.4. By Application (Nuclear Medicine, Medical Imaging, Precision Medicine, Oncology, Others)
8.2.5. By Country
8.3. North America: Country Analysis
8.3.1. United States Radiomics Market Outlook
8.3.1.1. Market Size & Forecast
8.3.1.1.1. By Value
8.3.1.2. Market Share & Forecast
8.3.1.2.1. By Modality
8.3.1.2.2. By Image Type
8.3.1.2.3. By Technology
8.3.1.2.4. By Application
8.3.2. Mexico Radiomics Market Outlook
8.3.2.1. Market Size & Forecast
8.3.2.1.1. By Value
8.3.2.2. Market Share & Forecast
8.3.2.2.1. By Modality
8.3.2.2.2. By Image Type
8.3.2.2.3. By Technology
8.3.2.2.4. By Application
8.3.3. Canada Radiomics Market Outlook
8.3.3.1. Market Size & Forecast
8.3.3.1.1. By Value
8.3.3.2. Market Share & Forecast
8.3.3.2.1. By Modality
8.3.3.2.2. By Image Type
8.3.3.2.3. By Technology
8.3.3.2.4. By Application
9. Europe Radiomics Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1. By Modality (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron-Emission-Tomography (PET), Others)
9.2.2. By Image Type (2D v/s 3D)
9.2.3. By Technology (Engineered Features v/s Deep Learning)
9.2.4. By Application (Nuclear Medicine, Medical Imaging, Precision Medicine, Oncology, Others)
9.2.5. By Country
9.3. Europe: Country Analysis
9.3.1. France Radiomics Market Outlook
9.3.1.1. Market Size & Forecast
9.3.1.1.1. By Value
9.3.1.2. Market Share & Forecast
9.3.1.2.1. By Modality
9.3.1.2.2. By Image Type
9.3.1.2.3. By Technology
9.3.1.2.4. By Application
9.3.2. Germany Radiomics Market Outlook
9.3.2.1. Market Size & Forecast
9.3.2.1.1. By Value
9.3.2.2. Market Share & Forecast
9.3.2.2.1. By Modality
9.3.2.2.2. By Image Type
9.3.2.2.3. By Technology
9.3.2.2.4. By Application
9.3.3. United Kingdom Radiomics Market Outlook
9.3.3.1. Market Size & Forecast
9.3.3.1.1. By Value
9.3.3.2. Market Share & Forecast
9.3.3.2.1. By Modality
9.3.3.2.2. By Image Type
9.3.3.2.3. By Technology
9.3.3.2.4. By Application
9.3.4. Italy Radiomics Market Outlook
9.3.4.1. Market Size & Forecast
9.3.4.1.1. By Value
9.3.4.2. Market Share & Forecast
9.3.4.2.1. By Modality
9.3.4.2.2. By Image Type
9.3.4.2.3. By Technology
9.3.4.2.4. By Application
9.3.5. Spain Radiomics Market Outlook
9.3.5.1. Market Size & Forecast
9.3.5.1.1. By Value
9.3.5.2. Market Share & Forecast
9.3.5.2.1. By Modality
9.3.5.2.2. By Image Type
9.3.5.2.3. By Technology
9.3.5.2.4. By Application
10. Asia-Pacific Radiomics Market Outlook
10.1. Market Size & Forecast
10.1.1. By Value
10.2. Market Share & Forecast
10.2.1. By Modality (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron-Emission-Tomography (PET), Others)
10.2.2. By Image Type (2D v/s 3D)
10.2.3. By Technology (Engineered Features v/s Deep Learning)
10.2.4. By Application (Nuclear Medicine, Medical Imaging, Precision Medicine, Oncology, Others)
10.2.5. By Country
10.3. Asia-Pacific: Country Analysis
10.3.1. China Radiomics Market Outlook
10.3.1.1. Market Size & Forecast
10.3.1.1.1. By Value
10.3.1.2. Market Share & Forecast
10.3.1.2.1. By Modality
10.3.1.2.2. By Image Type
10.3.1.2.3. By Technology
10.3.1.2.4. By Application
10.3.2. India Radiomics Market Outlook
10.3.2.1. Market Size & Forecast
10.3.2.1.1. By Value
10.3.2.2. Market Share & Forecast
10.3.2.2.1. By Modality
10.3.2.2.2. By Image Type
10.3.2.2.3. By Technology
10.3.2.2.4. By Application
10.3.3. Japan Radiomics Market Outlook
10.3.3.1. Market Size & Forecast
10.3.3.1.1. By Value
10.3.3.2. Market Share & Forecast
10.3.3.2.1. By Modality
10.3.3.2.2. By Image Type
10.3.3.2.3. By Technology
10.3.3.2.4. By Application
10.3.4. South Korea Radiomics Market Outlook
10.3.4.1. Market Size & Forecast
10.3.4.1.1. By Value
10.3.4.2. Market Share & Forecast
10.3.4.2.1. By Modality
10.3.4.2.2. By Image Type
10.3.4.2.3. By Technology
10.3.4.2.4. By Application
10.3.5. Australia Radiomics Market Outlook
10.3.5.1. Market Size & Forecast
10.3.5.1.1. By Value
10.3.5.2. Market Share & Forecast
10.3.5.2.1. By Modality
10.3.5.2.2. By Image Type
10.3.5.2.3. By Technology
10.3.5.2.4. By Application
11. South America Radiomics Market Outlook
11.1. Market Size & Forecast
11.1.1. By Value
11.2. Market Share & Forecast
11.2.1. By Modality (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron-Emission-Tomography (PET), Others)
11.2.2. By Image Type (2D v/s 3D)
11.2.3. By Technology (Engineered Features v/s Deep Learning)
11.2.4. By Application (Nuclear Medicine, Medical Imaging, Precision Medicine, Oncology, Others)
11.2.5. By Country
11.3. South America: Country Analysis
11.3.1. Brazil Radiomics Market Outlook
11.3.1.1. Market Size & Forecast
11.3.1.1.1. By Value
11.3.1.2. Market Share & Forecast
11.3.1.2.1. By Modality
11.3.1.2.2. By Image Type
11.3.1.2.3. By Technology
11.3.1.2.4. By Application
11.3.2. Argentina Radiomics Market Outlook
11.3.2.1. Market Size & Forecast
11.3.2.1.1. By Value
11.3.2.2. Market Share & Forecast
11.3.2.2.1. By Modality
11.3.2.2.2. By Image Type
11.3.2.2.3. By Technology
11.3.2.2.4. By Application
11.3.3. Colombia Radiomics Market Outlook
11.3.3.1. Market Size & Forecast
11.3.3.1.1. By Value
11.3.3.2. Market Share & Forecast
11.3.3.2.1. By Modality
11.3.3.2.2. By Image Type
11.3.3.2.3. By Technology
11.3.3.2.4. By Application
12. Middle East and Africa Radiomics Market Outlook
12.1. Market Size & Forecast
12.1.1. By Value
12.2. Market Share & Forecast
12.2.1. By Modality (Magnetic Resonance Imaging (MRI), Computed Tomography (CT), Positron-Emission-Tomography (PET), Others)
12.2.2. By Image Type (2D v/s 3D)
12.2.3. By Technology (Engineered Features v/s Deep Learning)
12.2.4. By Application (Nuclear Medicine, Medical Imaging, Precision Medicine, Oncology, Others)
12.2.5. By Country
12.3. MEA: Country Analysis
12.3.1. South Africa Radiomics Market Outlook
12.3.1.1. Market Size & Forecast
12.3.1.1.1. By Value
12.3.1.2. Market Share & Forecast
12.3.1.2.1. By Modality
12.3.1.2.2. By Image Type
12.3.1.2.3. By Technology
12.3.1.2.4. By Application
12.3.2. Saudi Arabia Radiomics Market Outlook
12.3.2.1. Market Size & Forecast
12.3.2.1.1. By Value
12.3.2.2. Market Share & Forecast
12.3.2.2.1. By Modality
12.3.2.2.2. By Image Type
12.3.2.2.3. By Technology
12.3.2.2.4. By Application
12.3.3. UAE Radiomics Market Outlook
12.3.3.1. Market Size & Forecast
12.3.3.1.1. By Value
12.3.3.2. Market Share & Forecast
12.3.3.2.1. By Modality
12.3.3.2.2. By Image Type
12.3.3.2.3. By Technology
12.3.3.2.4. By Application
12.3.4. Kuwait Radiomics Market Outlook
12.3.4.1. Market Size & Forecast
12.3.4.1.1. By Value
12.3.4.2. Market Share & Forecast
12.3.4.2.1. By Modality
12.3.4.2.2. By Image Type
12.3.4.2.3. By Technology
12.3.4.2.4. By Application
13. Market Dynamics
13.1. Drivers
13.1.1. Integration of Artificial Intelligence in Medical Imaging
13.1.2. Increased Reliance Radiology for Medical Diagnosis
13.1.3. Growing Population with Cancer and Cardiovascular Disorders
13.2. Challenges
13.2.1. Imaging Protocols Not Standardized/Technological Restraints
13.2.2. Budget Cuts of Hospitals
13.2.3. Lack of Validation and Risk of False-Positive Results
14. Market Trends & Developments
14.1. Growing Research and Investment Activities
14.2. Opportunities in Emerging Countries
14.3. Adoption of Better Healthcare Facilities
15. Competitive Landscape
15.1. Business Overview
15.2. Company Snapshot
15.3. Products & Services
15.4. Financials (As Reported)
15.5. Recent Developments
15.6. SWOT Analysis
15.6.1. Radiomics.io (Computational Imaging & Bioinformatics Lab)
15.6.2. Radiomics Bio (Belgium)
15.6.3. Health Innovation Ventures (HIV)
15.6.4. Sophia Genetics SA
15.6.5. HealthMyne Inc
15.6.6. Oncoradiomics
15.6.7. ptTheragnostic BV
16. Strategic Recommendations
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security